The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it none, with a mean price target of $14. Insiders have been net buyers over the past quarter.
MINISO Group Holding Limited
MNSO · the NYSE · USD · Market cap $3.2B
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price11.70 USD at the 18 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 18 Nov 2026
- Our regime readAccumulation, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.39)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $17.10 to $23.40, base estimate $17.10 (screen dated 2026-11-18).
- Trend Accumulation
- Insiders insiders bought, latest filing 2026-09-29
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.39, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
MINISO Group Holding Limited holds its Accumulation at $11.70. Consolidating, no directional conviction, held for 46 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 46 days |
| Price at the screen | $11.70 |
| Valuation | 18.71 trailing · 7.49 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.13 |
Five Screens: MNSO's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 256.67% | Below 33% | Fail |
| Interest-bearing cash | 166.69% | Below 33% | Fail |
| Receivables | 0.00% | Below 49% | Pass |
| Revenue purity | 0.49% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
MINISO's business is in a permissible area, but its interest-bearing debt is about 257% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MNSO's ethical verdict changes
Today MNSO does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 18 Nov 2026: it trades at roughly a 32% discount to our $17.10 fair value, moderate competitive moat, 17.00% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. A 31.6% discount to the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +17% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $17.10, with a range of $17.10 to $23.40, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsCheap shelves hide a debt problem
Walk into a MINISO store and the low prices feel clever, almost too good to be true for everyday gadgets and home goods. The business is growing revenue at 28 percent, turning a 9 percent profit margin and delivering 19 percent return on equity, all at a forward multiple of just 7.6 times. Yet the numbers sit unused because the company fails our ethical screen on its debt ratio.
We pass for that single reason. A moderate moat and a wide gap to our fair value of 23.82 do not override the debt issue, even when fifteen analysts point to a 20 dollar median target. Consumer cyclical names often look this inexpensive precisely when earnings sit near a peak, and low multiples can simply mark the start of the next downturn rather than a bargain.
The real risk sits in how quickly margins and returns could compress if consumer spending slows or if higher interest costs eat into the cash flow that currently supports the balance sheet. Currency swings and store expansion delays add further pressure in a sector where debt already raises the stakes.
Analysis, not advice.
| Forward P/E | 7.5xcheap for a company growing this fast |
| Trailing P/E | 18.7xreasonably valued |
| EPS, trailing | 0.59 |
| EPS, forward | 1.47 |
| Revenue growth | +17.0%steady growth |
| Profit margin | 5.4%thin but positive margins |
| Return on equity | 11.8%a modest return on shareholder capital |
| FCF yield | 71.10% |
| Dividend yield | 3.22% |
| Debt to equity | 1.27a meaningful debt load worth watching |
| Current ratio | 1.57healthy short-term liquidity |
| Beta | 0.13barely tracks the market's swings |
| Short interest, float | 0.02% |
| 52-week range | 8.55 - 22.33 |
| Moat | MODERATE |
| Market cap | $3.2B |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $14. Insiders have been net buyers over the past quarter.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $14. Insiders have been net buyers over the past quarter.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $14. Insiders have been net buyers over the past quarter.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $14. Insiders have been net buyers over the past quarter.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $15. Insiders have been net buyers over the past quarter.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $15. Insiders have been net buyers over the past quarter.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 22.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (16 analysts) rates it buy, with a mean price target of $15.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it strong buy, with a mean price target of $23.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (14 analysts) rates it strong buy, with a mean price target of $23.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is Global Store Expansion Altering The Investment Case For MINISO Stock (MNSO)? Yahoo Finance · 7d ago
- Is MINISO Group Holding (NYSE:MNSO) Trading At A Discount To Cash Flow? Yahoo Finance · 8d ago
- MINISO Group Holding (MNSO) Rebounds Over 12% In 30 Days, Is It Still A Bargain? Yahoo Finance · 8d ago
- MINISO Group Holding Limited Unsponsored ADR (MNSO) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance · 9d ago
- MINISO Group Holding Limited Unsponsored ADR (MNSO) Stock Sinks As Market Gains: Here's Why Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Zhang Jingjing Eason | VP, CFO | P - Purchase | 150,600 | $340,100 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $10.25 | +14.2% | · | $1,142 | +14.2% |
| 2 months | $8.60 | +36.1% | · | $1,361 | +36.1% |
| 3 months | $11.13 | +5.1% | · | $1,051 | +5.1% |
| 6 months | $13.53 | -13.5% | · | $865 | -13.5% |
| 1 year | $20.66 | -43.4% | $0.38 | $584 | -41.6% |
| 2 years | $16.93 | -30.9% | $0.70 | $732 | -26.8% |
| 3 years | $24.69 | -52.6% | $1.27 | $525 | -47.5% |
| 5 years | $12.53 | -6.6% | $1.85 | $1,082 | +8.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MNSO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.